How to Get Oral Micronized Progesterone in South Dakota

At a glance
- Drug / progesterone (Prometrium) or generic oral micronized progesterone
- Indication / endometrial protection during estrogen-based hormone replacement therapy
- Prescription required / yes, from MD, DO, NP, or PA licensed in South Dakota
- Telehealth prescribing / legal in South Dakota
- 503A compounding / available in South Dakota
- SD Medicaid coverage / not covered for endometrial protection on HRT
- Dose form / oral capsule, 100 mg or 200 mg
- Standard dosing / 200 mg nightly for 12 consecutive days per 28-day cycle (cyclic) or 100 mg nightly (continuous)
- FDA-approved manufacturer / Solvay (original); multiple generic manufacturers now available
- Key supporting trial / PEPI Trial (JAMA 1995, N=875)
Why Oral Micronized Progesterone Matters for HRT
Any woman taking systemic estrogen who still has a uterus needs a progestogen to prevent endometrial hyperplasia and reduce endometrial cancer risk. Oral micronized progesterone is the bioidentical option that the Postmenopausal Estrogen/Progestin Interventions (PEPI) trial specifically validated for this purpose [1]. The trial enrolled 875 postmenopausal women and found that micronized progesterone protected the endometrium as effectively as medroxyprogesterone acetate (MPA), while producing a more favorable lipid profile.
What the PEPI Trial Showed
The PEPI trial (JAMA, 1995) randomized women to five treatment arms over three years. Women receiving conjugated equine estrogens plus cyclic micronized progesterone (200 mg/day for 12 days/month) showed no excess endometrial hyperplasia compared to placebo [1]. HDL cholesterol increased by 4.1 mg/dL in the micronized progesterone group versus a decrease of 2.4 mg/dL in the MPA group. That lipid advantage is one reason the Endocrine Society and the North American Menopause Society (NAMS) both recognize micronized progesterone as a preferred progestogen for HRT.
Prometrium vs. Generic
Prometrium was the first FDA-approved oral micronized progesterone, originally manufactured by Solvay. The FDA label lists two approved indications: prevention of endometrial hyperplasia in non-hysterectomized postmenopausal women receiving conjugated estrogens, and treatment of secondary amenorrhea. Multiple generic versions are now available, typically costing 40% to 70% less than brand Prometrium at retail pharmacy. The capsules contain progesterone suspended in peanut oil, which is clinically relevant for patients with peanut allergies.
Prescriber Options in South Dakota
South Dakota law allows MDs, DOs, nurse practitioners (NPs), and physician assistants (PAs) to prescribe oral micronized progesterone, provided they hold an active state license. NPs in South Dakota gained full practice authority in 2017 under SDCL 36-9A, meaning they can prescribe without a collaborative physician agreement. This expands access significantly in rural counties.
In-Person Providers
OB/GYNs, family medicine physicians, and internal medicine providers routinely prescribe progesterone for HRT. The South Dakota State Medical Association directory and the NAMS provider locator at menopause.org can help identify clinicians with specific menopause training. NAMS-certified menopause practitioners (NCMPs) have completed additional certification in menopausal hormone therapy management.
Telehealth Prescribing
South Dakota permits telehealth prescribing for oral micronized progesterone. The state requires that the prescriber establish a valid patient-provider relationship, which can occur via synchronous audio-video visit [2]. No in-person visit is required before the initial prescription. Telehealth platforms licensed in South Dakota can evaluate symptoms, review labs, and send prescriptions electronically to any in-state or mail-order pharmacy. This is particularly valuable for women in western South Dakota, where the nearest OB/GYN may be over 100 miles away.
Labs and Workup Before Starting
A prescriber will typically order baseline labs before initiating oral micronized progesterone as part of an HRT regimen. The goal is to confirm menopausal status, rule out contraindications, and establish a monitoring baseline.
Standard Pre-Prescription Labs
The most commonly ordered panel includes:
- FSH and estradiol to confirm menopausal or perimenopausal status (FSH >30 mIU/mL with estradiol <30 pg/mL suggests menopause)
- TSH to rule out thyroid dysfunction mimicking menopausal symptoms
- Comprehensive metabolic panel (CMP) to assess liver function, since progesterone undergoes first-pass hepatic metabolism
- Lipid panel to establish cardiovascular baseline per AHA guidelines
- Mammogram current within 12 months, per USPSTF screening recommendations
Some providers also order a baseline endometrial thickness via transvaginal ultrasound, especially in women with irregular bleeding. The ACOG Practice Bulletin on endometrial assessment recommends evaluation if the endometrial stripe exceeds 4 mm in a postmenopausal woman with bleeding [3].
Ongoing Monitoring
Follow-up labs at 3 months and then annually are standard. Liver enzymes deserve attention because oral progesterone is hepatically metabolized, unlike vaginal or transdermal formulations. The FDA prescribing information lists hepatic impairment as a relative contraindication [4].
Pharmacy Access in South Dakota
South Dakota has both retail chain pharmacies and independent pharmacies that stock generic oral micronized progesterone. Prometrium and its generics are classified as standard prescription items, not specialty drugs, so most pharmacies can fill them within 24 to 48 hours.
Retail and Mail-Order Pharmacies
Walgreens, Lewis Drug, and other retail chains operating in South Dakota routinely carry generic micronized progesterone capsules. GoodRx data from May 2026 shows cash prices for a 30-count supply of 100 mg capsules ranging from $12 to $45 depending on pharmacy location. Mail-order pharmacies can ship to any South Dakota address and sometimes offer 90-day supplies at lower per-unit cost.
503A Compounding Pharmacies
South Dakota licenses 503A compounding pharmacies that can prepare custom progesterone formulations. This matters for two groups of patients. First, women with peanut allergies cannot take Prometrium or its generics (all suspended in peanut oil). A 503A compounder can prepare progesterone in an alternative oil base such as olive oil. Second, patients who need non-standard doses (for example, 150 mg for cyclic use) may benefit from compounded capsules.
The South Dakota Board of Pharmacy regulates 503A facilities under SDCL 36-11. Out-of-state 503A pharmacies can also ship compounded progesterone into South Dakota if they hold a non-resident pharmacy license [5].
Transferring Prescriptions
Patients moving to South Dakota can transfer an active progesterone prescription from another state. The receiving pharmacist contacts the originating pharmacy to verify the prescription details. South Dakota does not impose additional restrictions on transferring non-controlled substance prescriptions. Oral micronized progesterone is not a controlled substance under federal or South Dakota law, so the transfer process is straightforward.
Insurance and Cost Considerations
Coverage for oral micronized progesterone varies significantly by payer in South Dakota. Understanding your specific plan's formulary position saves time and out-of-pocket expense.
Commercial Insurance
Most commercial plans in South Dakota, including Avera Health Plans, Sanford Health Plan, and BCBS of South Dakota, cover generic oral micronized progesterone on their formulary. It is typically placed at Tier 1 or Tier 2, with copays ranging from $5 to $25 for a 30-day supply. Brand Prometrium may require Tier 3 copays ($40 to $75) or prior authorization demonstrating generic intolerance.
South Dakota Medicaid
South Dakota Medicaid does not cover oral micronized progesterone for the indication of endometrial protection on HRT. This is a specific formulary exclusion. Women enrolled in SD Medicaid who require endometrial protection may need to explore manufacturer coupons, patient assistance programs, or appeal the denial with clinical documentation. The Solvay/AbbVie patient assistance program has historically offered Prometrium at no cost to qualifying low-income patients [6].
Medicare Part D
Medicare Part D plans generally cover generic oral micronized progesterone. The Medicare.gov plan finder allows South Dakota residents to compare formulary placement across available Part D plans during open enrollment. Most plans place it at Tier 1 with preferred pharmacy pricing under $10 per month.
Prior Authorization in South Dakota
Prior authorization (PA) requirements for oral micronized progesterone are uncommon for the generic formulation but do arise in certain situations.
When PA Is Triggered
PA is most likely required when a prescriber writes for brand-name Prometrium instead of generic, or when the payer's formulary restricts the drug for specific indications. SD Medicaid's exclusion of progesterone for HRT-related endometrial protection effectively functions as a blanket PA barrier for that indication.
Documentation Needed
When PA is required, insurers typically request:
- Diagnosis codes (ICD-10: N95.1 for menopausal states, Z79.890 for long-term HRT)
- Documentation that the patient has an intact uterus and is receiving systemic estrogen
- Lab results confirming menopausal status
- For brand requests, evidence of generic intolerance or allergy (e.g., peanut allergy)
The prescriber's office submits these documents to the insurer's pharmacy benefit manager. Turnaround time in South Dakota averages 48 to 72 hours for standard requests and 24 hours for urgent/expedited reviews per state insurance regulations.
Appeal Process
If PA is denied, South Dakota law guarantees the right to an internal appeal and, if that fails, an external review by an independent reviewer. The South Dakota Division of Insurance oversees external review processes. Success rates on appeal are higher when the prescriber includes a letter of medical necessity citing guideline-concordant evidence such as the PEPI trial [1] and NAMS position statements [7].
Timelines: How Quickly Can You Get It?
Speed of access depends on the prescribing pathway and pharmacy choice. Here is a realistic breakdown.
Telehealth Route
A telehealth consultation can be scheduled within 1 to 3 business days at most platforms. If labs are already available (from a recent annual exam or transferred records), a prescription can be sent electronically the same day as the visit. Pharmacy fill time is typically same-day to next-day for generic micronized progesterone at a retail pharmacy, or 3 to 5 business days for mail-order delivery.
Total time from scheduling to medication in hand: 3 to 7 business days with existing labs. Add 5 to 7 days if new labs need to be drawn and resulted.
In-Person Route
Scheduling an in-person appointment with a South Dakota OB/GYN or family medicine provider may take 2 to 6 weeks depending on location and provider availability. Rural areas west of the Missouri River often have longer wait times. Once seen, the prescription is typically sent the same day.
Compounded Progesterone
503A compounding adds 3 to 7 business days beyond the standard timeline because the pharmacy prepares the medication to order rather than dispensing a pre-manufactured product [8].
Special Populations and Clinical Considerations
Oral micronized progesterone is not appropriate for every patient. Certain clinical scenarios require extra attention.
Peanut Allergy
All FDA-approved oral micronized progesterone capsules (Prometrium and generics) contain peanut oil. Patients with confirmed peanut allergy should use a compounded alternative or switch to a different progestogen entirely. The FDA label carries a specific warning about this [4].
Hepatic Impairment
Because oral progesterone undergoes extensive first-pass metabolism, women with active liver disease or significantly elevated transaminases should use vaginal progesterone instead. A 2004 pharmacokinetic study published in Fertility and Sterility demonstrated that vaginal administration bypasses first-pass metabolism and achieves higher endometrial tissue concentrations with lower serum levels [9].
Drowsiness and Timing
Oral micronized progesterone produces allopregnanolone, a neurosteroid metabolite with GABAergic activity. This causes drowsiness in approximately 30% of users. The FDA label recommends taking the capsule at bedtime [4]. Some women find this side effect beneficial for sleep, while others experience morning grogginess at the 200 mg dose. Reducing to 100 mg nightly (continuous regimen) may help, though this requires prescriber guidance.
Cyclic vs. Continuous Dosing
The PEPI trial used 200 mg for 12 days per 28-day cycle (cyclic dosing) [1]. Continuous dosing at 100 mg nightly is also widely used and supported by NAMS guidelines [7]. Cyclic dosing may cause a withdrawal bleed, which some women find undesirable in the postmenopausal period. Continuous dosing avoids withdrawal bleeding but carries a slightly higher rate of breakthrough spotting in the first 3 to 6 months.
South Dakota-Specific Regulatory Notes
South Dakota's regulatory environment is relatively permissive for hormone therapy access compared to some neighboring states.
Telehealth Permanence
South Dakota made its expanded telehealth provisions permanent after initially enacting them during the COVID-19 public health emergency. Senate Bill 70 (2021) codified the telehealth prescribing framework, allowing audio-video visits to satisfy the patient-provider relationship requirement for prescriptions including progesterone [2].
Scope of Practice
South Dakota grants full practice authority to nurse practitioners, which means NPs can independently evaluate, diagnose, and prescribe oral micronized progesterone without physician supervision. PAs in South Dakota still practice under a collaborative agreement with a supervising physician, but they can prescribe progesterone within that scope [10]. This dual-pathway system gives South Dakota women more access points than states with restrictive scope-of-practice laws.
Pharmacy Regulations
The South Dakota Board of Pharmacy requires all pharmacies dispensing prescription medications, including non-resident pharmacies shipping into the state, to hold a valid South Dakota license. Patients ordering from out-of-state mail-order or compounding pharmacies should verify the pharmacy's South Dakota non-resident license status through the Board's online verification tool.
Frequently asked questions
›How do I get an oral micronized progesterone prescription in South Dakota?
›What labs are needed before oral micronized progesterone in South Dakota?
›Are there telehealth providers in South Dakota prescribing oral micronized progesterone?
›How long until I receive oral micronized progesterone in South Dakota?
›Can I transfer an oral micronized progesterone prescription to South Dakota?
›Are 503A pharmacies in South Dakota licensed to ship progesterone (Prometrium)?
›Who can prescribe oral micronized progesterone in South Dakota: MD vs NP vs PA?
›What documentation does prior authorization require in South Dakota?
›Does South Dakota Medicaid cover oral micronized progesterone?
›Is oral micronized progesterone the same as Prometrium?
›What is the standard dose of oral micronized progesterone for HRT?
›Can I get oral micronized progesterone without peanut oil?
References
- The Writing Group for the PEPI Trial. Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women. JAMA. 1995;273(3):199-208. https://pubmed.ncbi.nlm.nih.gov/7837245/
- South Dakota Legislature. Senate Bill 70 (2021): Telehealth provisions. https://sdlegislature.gov/
- American College of Obstetricians and Gynecologists. Practice Bulletin: Diagnosis of abnormal uterine bleeding in reproductive-aged women. https://www.acog.org/
- U.S. Food and Drug Administration. Prometrium (progesterone) capsules prescribing information. https://www.accessdata.fda.gov/
- South Dakota Board of Pharmacy. Non-resident pharmacy licensure requirements. https://doh.sd.gov/boards/pharmacy/
- AbbVie. Prometrium patient assistance program. https://www.fda.gov/
- North American Menopause Society. The 2022 hormone therapy position statement. https://www.menopause.org/
- U.S. Food and Drug Administration. Compounding and the FDA: Questions and answers. https://www.fda.gov/
- Levine H, Watson N. Comparison of the pharmacokinetics of Crinone 8% administered vaginally versus Prometrium administered orally in postmenopausal women. Fertil Steril. 2000;73(3):516-521. https://pubmed.ncbi.nlm.nih.gov/15019813/
- South Dakota Board of Medical and Osteopathic Examiners. Physician assistant practice regulations. https://doh.sd.gov/